Isopropylbenzene

Isopropylbenzene

SCHEMBL27936717

CC(C)c1ccccc1.Cc1ccccc1.OO

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.58
TSHR P16473 2/20 0.58
ALOX12 P18054 2/20 0.58
ACHE P22303 1/20 0.58
ADRA2C P18825 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ADRA2A P08913 1/20 0.44
HIF1A Q16665 1/20 0.44
ALDH1A1 P00352 2/20 0.43
ACP3 P15309 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CHRM2 P08172 1/20 0.41
ADRA1A P35348 1/20 0.41
RGS12 O14924 1/20 0.41
GLA P06280 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropylbenzene SCHEMBL3475008 0.97 LMNA (0.61) LMNATSHRALOX12ACHEADRA2C
Isopropylbenzene SCHEMBL338185 0.97 LMNA (0.61) LMNATSHRALOX12ACHEADRA2C
Toluene SCHEMBL29188898 0.92 LMNA (0.61) LMNATSHRALOX12ACHEKDM4E
P-Cymene SCHEMBL8208471 0.90 ACHE (0.58) LMNATSHRALOX12ACHEHIF1A
P-Cymene SCHEMBL10942903 0.90 ACHE (0.58) LMNATSHRALOX12ACHEHIF1A
P-Cymene SCHEMBL1292746 0.90 ACHE (0.50) LMNATSHRALOX12ACHESMN1; SMN2
Isopropylbenzene SCHEMBL23421101 0.89 ADRA2C (0.52) LMNATSHRALOX12ADRA2CKDM4E
Isopropylbenzene SCHEMBL4795494 0.89 ADRA2C (0.52) LMNATSHRALOX12ADRA2CKDM4E
Isopropylbenzene SCHEMBL16627 0.89 ADRA2C (0.52) LMNATSHRALOX12ADRA2CKDM4E
Isopropylbenzene SCHEMBL30804544 0.89 ADRA2C (0.52) LMNATSHRALOX12ADRA2CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109912569-B Novel preparation method of esomeprazole magnesium trihydrate and intermediate thereof 浙江康德药业集团股份有限公司 2020-10-27 CN claimed
CN-103570686-B Method for synthesizing and refining esomeprazole sodium HARBIN PHARMACEUTICAL GROUP TECHNOLOGY CT 2015-04-01 CN claimed
CN-103570686-A Method for synthesizing and refining esomeprazole sodium HARBIN PHARMACEUTICAL GROUP TECHNOLOGY CT 2014-02-12 CN claimed
CN-109912569-B Novel preparation method of esomeprazole magnesium trihydrate and intermediate thereof 浙江康德药业集团股份有限公司 2020-10-27 CN disclosed
CN-103936715-B The process for purification of a kind of Esomeprazole sodium and synthetic method 哈尔滨珍宝制药有限公司 2016-08-24 CN disclosed
CN-103570686-B Method for synthesizing and refining esomeprazole sodium HARBIN PHARMACEUTICAL GROUP TECHNOLOGY CT 2015-04-01 CN disclosed
CN-103936715-A Refining method and synthesis method of esomeprazole HARBIN ZHENBAO PHARMACEUTICAL CO LTD 2014-07-23 CN disclosed
CN-103570686-A Method for synthesizing and refining esomeprazole sodium HARBIN PHARMACEUTICAL GROUP TECHNOLOGY CT 2014-02-12 CN disclosed